Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BCRX compared with MNPR: revenue, margins and what each company keeps, and the suppliers and customers both name
BCRX
Biocryst Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
vs
Compare
BCRX
Biocryst Pharmaceuticals Inc
vs
MNPR
Monopar Therapeutics
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
BCRX
Biocryst Pharmaceuticals Inc
Change
7.60
▼
−7.79%
· post 7.50
Mkt cap
$2.1B
Revenue
$180M
Q3 FY26
Revenue
$875M
FY25
MNPR
Monopar Therapeutics
Change
68.60
▼
−5.78%
· post 68.60
Closed
Nov 5 '26
Mkt cap
$488.7M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 5 '26
BCRX
Biocryst Pharmaceuticals Inc
vs
MNPR
Monopar Therapeutics
7.60
▼
−7.79%
post 7.50
Price
68.60
▼
−5.78%
post 68.60
$2.1B
Mkt cap
$488.7M
Q3 FY26
$180M
Revenue
—
FY25
$875M
Revenue
—
Change
Change
BCRX
7.60
▼
−7.79%
vs
MNPR
68.60
▼
−5.78%
Closed
Nov 5 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BCRX, solid
MNPR, dashed